Overview

Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation

Status:
Completed
Trial end date:
2019-01-21
Target enrollment:
Participant gender:
Summary
This study evaluates pupil dilation using fixed combination phenylephrine-tropicamide vs. a placebo. Participants must attend 3 visits where either the investigational drug or a placebo will be administered to both eyes. Afterwards, pupil dilation and safety assessments will be performed at specific time intervals.
Phase:
Phase 3
Details
Lead Sponsor:
Eyenovia Inc.
Treatments:
Ophthalmic Solutions
Oxymetazoline
Pharmaceutical Solutions
Phenylephrine
Tropicamide